Benefits of Sodium-Glucose Cotransporter-2 Inhibitors with Renin-Angiotensin System Blockers in Type-2 Diabetes: A Cohort Analysis.

Med Sci Monit · 2025 · PMC12144920 · PMID 40457614

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Nevertheless, the data suggests a favorable trend using this combination therapy ( Figure 3B ).

also in 887 other papers

a positive trendno p-value reported

Additionally, subgroup analyses indicate a positive trend in favor of combination therapy.

also in 5,550 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.